Skip to main content

Tweets

ASK CUSH ANYTHING! Rheums: Have a question for Dr. Cush? Record it here and we may feature it on an upcoming podcast. #RheumNow https://t.co/wzNmOzH4VE https://t.co/KzPzWpSoW1
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
Metabolic syndrome (MetS) is associated with radiographic & nodal hand OA (HOA). 896 MetS positive & 1613 w/o MetS assessed w/ propensity matching. MetS had more xray HOA ((OR 1.32), PIPs (OR 1.52), DIPs (1.38), hand pain (1.25)https://t.co/aNEV5b6Tmv

Dr. John Cush @RheumNow ( View Tweet )

4 years 10 months ago
Malnutrition and Quality of Life in Elderly RA Patients https://t.co/4hEFTSaCga https://t.co/OPK3ThWqst
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
Patients with longstanding systemic lupus erythematosus (SLE) who were considered frail were more likely to accrue disease damage over time, a secondary analysis of data from a Chicago lupus cohort found. Read more on #RheumNow https://t.co/jQt5mFrMtS https://t.co/HljgqdKZtH
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
The AAOS has published their Clinical Practice Guideline for Management of Osteoarthritis of the Knee (Non-Arthroplasty); updating 19 of the 29 evidence-based recommendations and focuses on nonsurgical treatmentss to provide pain and patient function. https://t.co/faLi0X840d https://t.co/8iZkNEFkRy
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
Study of 380 nonintubated severe COVID-19 pneumonia patients showed that those with the highest tertiles of FERRITIN (1322-13 ,418) showed significant reduction in mortality (HR, 0.16; 0.06-0.45) if given methylprednisolone [120-240] mg https://t.co/Jr1aWlPpOk

Dr. John Cush @RheumNow ( View Tweet )

4 years 10 months ago
Secukinumab (IL-17 inhibitors) can be safely used in HIV spondyloarthritis patients. https://t.co/hpCRJkR9w7

Dr. John Cush @RheumNow ( View Tweet )

4 years 10 months ago
EHR record study: prevalence of Psoriatic arthritis (#PsA) was increased w/ psoriasis severity. PsA prevalence=2.9 per 100 PY; Based on severity - Mild 2.1/100PY; Moderate 9.9/100PY & severe PSO: PsA risk was 17.6/100PY https://t.co/hXeA773KN4 https://t.co/AUIYZiSq5k
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
Novel study of Pain Reprocessing Therapy;PRT in Chronic Back Pain. 151 pts w/ 10 yrs of LBP: 4 wk results - better w/ PRT (66%) (were pain-or nearly pain-free) vs PBO (20%) vs Usual care (10%), with gains maintained through 1-year follow-up https://t.co/lioI99GP80

Dr. John Cush @RheumNow ( View Tweet )

4 years 10 months ago
NEJM Clinical Images: Sweets syndrome (Acute Febrile Neutrophilic Dermatosis) - 46F w/ raised painful lesions on extremities. https://t.co/up5PviNDeS)

Dr. John Cush @RheumNow ( View Tweet )

4 years 10 months ago
ICYMI: New data from the CDC shows that obesity rates have risen in the USA during the pandemic, with 16 states having obesity rates of 35% or higher - that's four more than last year, adding Delaware, Iowa, Ohio and Texas to the list. https://t.co/9nFuea2BOV https://t.co/XmsXmFXhzv
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
POETYK PSO-1 and PSO-2 trial results seen at the EADV meeting, studying Tyk2 inhibitor, deucravacitinib vs PBO or apremilast in 666 & 1020 plaque psoriasis pts. Wk 16 PASI 75 higher in DEUC ((59%, 54%) vs Otezla (35%, 40%) vs PBO(13%,9%) https://t.co/qok68Kbb6J

Dr. John Cush @RheumNow ( View Tweet )

4 years 10 months ago
×